Live feed
·
INSIDERFiling
Atea Pharmaceuticals Inc. logo

Chief Development Officer Hammond Janet Mj converted options into 58,050 shares and covered exercise/tax liability with 14,136 shares, increasing direct ownership by 52% to 127,665 units (SEC Form 4)